Synopsys

SNPS

Market cap $80.5B

Synopsys (SNPS) is rated a Buy with a $519.12 12-month price target, reflecting derisked China headwinds and Ansys-driven growth. China-related revenue disruptions are fully factored into guidance, offering pure upside if conditions improve, while downside is limited. The Ansys acquisition expands SNPS's TAM by 1.5x and accelerates integration of multiphysics simulation, enhancing cross-selling and competitive positioning.

Synopsys is working with EMA and Cesium, part of Bentley Systems, to test equipment functionality by virtually replicating components, systems, and the lunar environment Key Highlights NASA's Johnson Space Center in Houston taps Synopsys and Electro Magnetic Applications, Inc. (EMA) to research Artemis spacesuit charging levels resulting from exposure to the lunar environment Cesium and Synopsys are collaborating with NASA SCaN's (Space Communications and Navigation) Lunar 3rd Generation Partnership Project (Lunar 3GPP) at the agency's Glenn Research Center in Cleveland to support cellular network rollout on the Moon Engineers at NASA Glenn are leveraging Synopsys' electromagnetic simulation solution to analyze the performance of antennas on spacesuits and rovers during simulated lunar missions SUNNYVALE, Calif., April 14, 2026  /PRNewswire/ -- NASA selected Synopsys, Inc. (NASDAQ: SNPS) and EMA to verify spacesuit compatibility with the lunar environment.

Synopsys (SNPS) concluded the recent trading session at $392.24, signifying a -3.13% move from its prior day's close.

Synopsys (SNPS) closed at $404.94 in the latest trading session, marking a -1.27% move from the prior day.

Recently, Zacks.com users have been paying close attention to Synopsys (SNPS). This makes it worthwhile to examine what the stock has in store.

SNPS' Design IP business faces near-term pressure, but strong AI-driven design wins and rising demand signal a potential rebound in fiscal 2026.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Synopsys remains a buy, offering a rare combination of secular growth, pricing power, and a discounted valuation after recent underperformance. SNPS is wrongly lumped with SaaS peers; its deeply integrated EDA business and non-seat-based pricing model insulate it from AI-driven software disruption. Elliott Investment Management's multibillion-dollar stake introduces a credible catalyst for operational improvements and a re-rating toward historical valuation norms.

Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock?

Synopsys (SNPS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.